Literature DB >> 1626815

Results of a directly observed intermittent isoniazid preventive therapy program in a shelter for homeless men.

V Nazar-Stewart1, C M Nolan.   

Abstract

We offered directly supervised isoniazid preventive therapy to middle-aged and elderly men who were exposed to tuberculosis during an outbreak of cases at a homeless shelter. Isoniazid, 900 mg, was administered twice weekly to men at the shelter and at the downtown Public Health Clinic. We report on compliance and adverse reactions associated with this preventive regimen. Isoniazid preventive therapy was offered to 64 men. Forty-seven men (73%) began therapy, and 23 of them (49%) completed the 6- to 12-month regimen. Men who failed to complete isoniazid therapy received a median of 11 biweekly doses (range, 1 to 41 doses) over a median of 9 wk (range, 3 to 37 wk). The most common reason for incomplete treatment was that the men no longer frequented the shelter. One hepatotoxic reaction occurred, for a 2.1% cumulative incidence among all men who started therapy and a 3.7% cumulative incidence among the 27 known alcoholic men who began therapy. In addition, we sought to identify personal characteristics of the men that might be associated with noncompliance. Out-of-state location of personal contacts in case of emergency was strongly associated with poor compliance. These data provide some assurance that directly supervised isoniazid preventive therapy may be offered safely to sheltered elderly men with a high prevalence of alcoholism. Further improvements in compliance with isoniazid preventive therapy in homeless populations may depend on the development of a therapeutic regimen of only 2 to 3 months duration.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1626815     DOI: 10.1164/ajrccm/146.1.57

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  6 in total

1.  Homelessness and health.

Authors:  S W Hwang
Journal:  CMAJ       Date:  2001-01-23       Impact factor: 8.262

2.  Tuberculosis screening and compliance with return for skin test reading among active drug users.

Authors:  C K Malotte; F Rhodes; K E Mais
Journal:  Am J Public Health       Date:  1998-05       Impact factor: 9.308

3.  Predictors of screening results for depressive symptoms among homeless adults in Los Angeles with latent tuberculosis.

Authors:  Jill Berg; Adeline Nyamathi; Ashley Christiani; Donald Morisky; Barbara Leake
Journal:  Res Nurs Health       Date:  2005-06       Impact factor: 2.228

4.  Incentives and accessibility: a pilot study to promote adherence to TB prophylaxis in a high-risk community.

Authors:  J Lorvick; S Thompson; B R Edlin; A H Kral; A R Lifson; J K Watters
Journal:  J Urban Health       Date:  1999-12       Impact factor: 3.671

5.  Treatment of latent Mycobacterium tuberculosis infection with 12 once weekly directly-observed doses of isoniazid and rifapentine among persons experiencing homelessness.

Authors:  Nwabunie Nwana; Suzanne M Marks; Edward Lan; Alicia H Chang; Michael Holcombe; Sapna Bamrah Morris
Journal:  PLoS One       Date:  2019-03-13       Impact factor: 3.240

6.  Evaluation of the isoniazid preventive therapy (IPT) program in Shurugwi District, Midlands Province, Zimbabwe, January 2013 to August 2014.

Authors:  Annamercy Makoni; Milton Chemhuru; Mufuta Tshimanga; Notion Tafara Gombe; More Mungati; Donewell Bangure
Journal:  BMC Res Notes       Date:  2015-09-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.